Prox1. By Western blot the antibody recognizes a ~83 kDa protein in fetal mouse brain lysate.
Immunogen
Recombinant human Prox1 protein.
Application
Anti-Prox1 Antibody, clone 4G10 is an antibody against Prox1 for use in WB, IH.
Research Category Neuroscience
Research Sub Category Developmental Neuroscience
Neuronal & Glial Markers
Western blot: 2 μg/mL
Optimal working dilutions must be determined by end user.
Target description
83 kDa
Linkage
Replaces: MABE488
Physical form
Format: Purified
Liquid in PBS with 0.1% sodium azide.
Protein A purified
Storage and Stability
Maintain at 2-8degC in undiluted aliquots for up to 6 months after date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
In schizophrenia (SCZ), neurons in the brain tend to undergo gross morphological changes, but the related molecular mechanism remains largely elusive. Using Kif3b+/- mice as a model with SCZ-like behaviors, we found that a high-betaine diet can significantly alleviate schizophrenic
Neurogenesis in embryonic sympathetic ganglia involves neuroblasts that resume proliferation following neuronal differentiation. As cell cycle exit is not associated with neuronal differentiation, the identity of proliferating neuroblasts is incompletely understood. Here, we use sympathetic ganglia of chick embryos to
Molecular cancer therapeutics, 15(6), 1332-1343 (2016-05-20)
Glioblastoma (GBM) is the most common malignant primary brain cancer. With a median survival of about a year, new approaches to treating this disease are necessary. To identify signaling molecules regulating GBM progression in a genetically engineered murine model of
Frontiers in neuroscience, 16, 816174-816174 (2022-04-12)
Alzheimer's disease (AD) is the most common condition in patients with dementia and affects a large population worldwide. The incidence of AD is expected to increase in future owing to the rapid expansion of the aged population globally. Researchers have
Development (Cambridge, England), 143(21), 3994-4002 (2016-11-03)
Fibroblast growth factor (FGF) signaling is an essential regulator of lens epithelial cell proliferation and survival, as well as lens fiber cell differentiation. However, the identities of these FGF factors, their source tissue and the genes that regulate their synthesis
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.